2021: OXPHOS-dependent radiosensitization of patient-derived organoids from pancreatic adenocarcinoma.

MLA

Kessler, Christopher, et al. “2021: OXPHOS-Dependent Radiosensitization of Patient-Derived Organoids from Pancreatic Adenocarcinoma.” Radiotherapy & Oncology, vol. 194, May 2024, pp. S5395–97. EBSCOhost, https://doi.org/10.1016/S0167-8140(24)02313-2.

APA

Kessler, C., Cadacio, F., Maurer, C., Schäfer, A., Schilling, D., Demir, I. E., Steiger, K., Schmid, R. M., Reichert, M., Combs, S. E., & Dobiasch, S. (2024). 2021: OXPHOS-dependent radiosensitization of patient-derived organoids from pancreatic adenocarcinoma. Radiotherapy & Oncology, 194, S5395–S5397. https://doi.org/10.1016/S0167-8140(24)02313-2

Chicago

Kessler, Christopher, Francheska Cadacio, Carlo Maurer, Arlett Schäfer, Daniela Schilling, Ihsan E. Demir, Katja Steiger, et al. 2024. “2021: OXPHOS-Dependent Radiosensitization of Patient-Derived Organoids from Pancreatic Adenocarcinoma.” Radiotherapy & Oncology 194 (May): S5395–97. doi:10.1016/S0167-8140(24)02313-2.